Product Description
CAY10575 is an inhibitor of IKK-ε. IKK-ε is a homolog of IKK-α and IKK-β which can activate NF-κB. NF-κB is activated upon degradation of IκB following IKK-α and IKK-β phosphorylation. CAY10575 is a benzimidazole analog that inhibits IKK-ε with an IC₅₀ value of ~15.8 µM.
CAY10575 is an inhibitor of IKK-ε. IKK-ε is a homolog of IKK-α and IKK-β which can activate NF-κB. NF-κB is activated upon degradation of IκB following IKK-α and IKK-β phosphorylation. CAY10575 is a benzimidazole analog that inhibits IKK-ε with an IC₅₀ value of ~15.8 µM.
Biovision | B2912 | CAY10575 DataSheet
Alternate Name/Synonyms: 5-(5,6-dimethoxybenzimidazol-1-yl)-3-[(4-methylsulfonylphenyl)methoxy]thiophene-2-carboxamide; BMCL191018 Compound 39; BDBM27444
Appearance: A crystalline solid
Formulation:
CAS Number: 916985-21-2
Structure Available?: True
Peptide sequence:
Salt Form: false
Molecular Formula: C₂₂H₂₁N₃O₆S₂
Molecular Weight: 487.6
Cell-Permeable?: True
Purity: ≥95%
Solubilities: ~10 mg/ml in in DMSO, ~1 mg/ml in DMF in 0
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: An inhibitor of IKK-ε
MDL Number: MFCD10567699
PubChem CID: 25190912
SMILES: COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=C(C=C4)S(=O)(=O)C)OC
InChi: InChI=1S/C22H21N3O6S2/c1-29-17-8-15-16(9-18(17)30-2)25(12-24-15)20-10-19(21(32-20)22(23)26)31-11-13-4-6-14(7-5-13)33(3,27)28/h4-10,12H,11H2,1-3H3,(H2,23,26)
InChi Key: